Assetmark Inc. Increases Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Key Points

• Assetmark Inc. significantly increased its stake in Henry Schein, Inc. by purchasing an additional 6,175 shares, raising its total holdings to 6,200 shares valued at $425,000.
• Total institutional ownership of Henry Schein accounts for a staggering 96.62% of the company's stock, reflecting high confidence among institutional investors.
• Henry Schein's latest earnings report showed a profit of $1.15 per share, exceeding analyst expectations, although revenue slightly declined compared to the previous year.

Assetmark Inc. lifted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 24,700.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,200 shares of the company's stock after acquiring an additional 6,175 shares during the quarter. Assetmark Inc.'s holdings in Henry Schein were worth $425,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Investment Management Corp VA ADV bought a new position in shares of Henry Schein in the fourth quarter worth about $32,000. Rakuten Securities Inc. bought a new position in Henry Schein in the first quarter valued at about $34,000. Whittier Trust Co. grew its holdings in shares of Henry Schein by 714.3% during the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after purchasing an additional 700 shares during the last quarter. UMB Bank n.a. grew its holdings in Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after acquiring an additional 201 shares during the last quarter. Finally, Allworth Financial LP lifted its holdings in Henry Schein by 24.5% during the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after buying an additional 232 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Stock Performance

NASDAQ HSIC traded up $2.04 during trading hours on Monday, reaching $70.02. 3,190,815 shares of the company were exchanged, compared to its average volume of 1,729,616. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. The business's 50 day simple moving average is $71.62 and its 200-day simple moving average is $71.32. The stock has a market capitalization of $8.52 billion, a P/E ratio of 21.88, a P/E/G ratio of 2.20 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. The business had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The business's revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.10 EPS. On average, equities research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. Wells Fargo & Company dropped their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Robert W. Baird reiterated a "neutral" rating and set a $72.00 target price (down previously from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday, July 14th. Finally, Barrington Research dropped their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. Nine investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $78.08.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.